Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Fielmann Group AGXSWX:FIE 80 3-Year Book Growth Rate is 7.00% as of Mar. 2026, which is 40% above its 10-year median of 5.00. GuruFocus rates XSWX:FIE with a GF Score™ of 80/100 and a GF Value™ of CHF52.66. The stock has 2 warning signs investors should review. Among 759 Medical Devices & Instruments companies, Fielmann Group AG ranks better than 66.27% on this metric.
During the past 12 months, Fielmann Group AG's average Book Value per Share Growth Rate was 8.10% per year.
During the past 3 years, the average Book Value per Share Growth Rate was 7.00% per year.
During the past 5 years, the average Book Value per Share Growth Rate was 4.30% per year.
During the past 10 years, the average Book Value per Share Growth Rate was 3.50% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.
During the past 13 years, the highest 3-Year average Book Value per Share Growth Rate of Fielmann Group AG was 11.30% per year. The lowest was 0.50% per year. And the median was 5.00% per year.
Fielmann Group AG (XSWX:FIE) 3-Year Book Growth Rate Explanation
Book Value per Share is the ratio of equity available to common shareholders divided by the shares outstanding. Book value per share effectively indicates a firm's net asset value on a per-share basis. It can be used by investors to gauge whether a stock price is undervalued by comparing it to the firm's market value per share. Theoretically, it is what the shareholders will receive if the company is liquidated.
Fielmann Group AG 3-Year Book Growth Rate Related Terms
XSWX:FIE vs ISRG, BDX, MDLN: 3-Year Book Growth Rate Comparison
For the Medical Instruments & Supplies subindustry, Fielmann Group AG's 3-Year Book Growth Rate, along with its competitors' market caps and 3-Year Book Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Fielmann Group AG 3-Year Book Growth Rate vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Fielmann Group AG's 3-Year Book Growth Rate distribution charts can be found below:
* The bar in red indicates where Fielmann Group AG's 3-Year Book Growth Rate falls into.
Fielmann Group AG 3-Year Book Growth Rate Calculation
This is the 3-year average growth rate of Book Value per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.
What does a 3-Year Book Growth Rate of 7.00% mean?
Fielmann Group AG (XSWX:FIE) has a 3-Year Book Growth Rate of 7.00% as of Mar. 2026. 3-Year Book Growth Rate is the 3-year average growth rate of Book Value per Share. View historical data for Fielmann Group AG and its competitors. This is 40% above median its historical median of 5.00. Over the past decade, Fielmann Group AG's 3-Year Book Growth Rate has ranged from 0.50 to 11.30. According to the industry distribution chart, Fielmann Group AG ranks #256 out of 759 companies in the Medical Devices & Instruments industry, placing it in the top 33.7%.
Is Fielmann Group AG's 3-Year Book Growth Rate too high?
Fielmann Group AG's current 3-Year Book Growth Rate of 7.00% is 40% above median its 10-year median of 5.00. Over the past 10 years, this metric has ranged from a low of 0.50 to a high of 11.30. The Medical Devices & Instruments industry median 3-Year Book Growth Rate is 2.30. Fielmann Group AG's value of 7.00% is 204.3% above this industry median. Based on the distribution chart, Fielmann Group AG ranks #256 out of 759 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Fielmann Group AG has a GF Score™ of 80/100, reflecting its overall financial health beyond just this single metric.
How does Fielmann Group AG's 3-Year Book Growth Rate compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Fielmann Group AG ranks #256 out of 759 companies for 3-Year Book Growth Rate. This puts Fielmann Group AG in the upper half of its industry. The industry median 3-Year Book Growth Rate is 2.30. Fielmann Group AG's value of 7.00% is 204.3% above this benchmark. Historically, Fielmann Group AG's own 3-Year Book Growth Rate has ranged from 0.50 to 11.30 over the past decade. While the company's 10-year median is 5.00 vs. the industry median of 2.30, Fielmann Group AG has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year Book Growth Rate for a Medical Devices & Instruments company?
The median 3-Year Book Growth Rate among Medical Devices & Instruments companies is 2.30, based on 759 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year Book Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year Book Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Fielmann Group AG's current 3-Year Book Growth Rate of 7.00% is 204.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year Book Growth Rate mean?
A high 3-Year Book Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year Book Growth Rate is the 3-year average growth rate of Book Value per Share. View historical data for Fielmann Group AG and its competitors. For the Medical Devices & Instruments industry, the median 3-Year Book Growth Rate is 2.30 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Fielmann Group AG's current 3-Year Book Growth Rate is 7.00%, which is 40% above median its own 10-year median of 5.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fielmann Group AG stock overvalued right now?
Fielmann Group AG (XSWX:FIE) has a current 3-Year Book Growth Rate of 7.00%. The stock's GF Value™ is CHF52.66, compared to a current price of CHF38.30 — trading 27.3% below its estimated fair value. The current 3-Year Book Growth Rate is 7.00%, which is 40% above median its 10-year median of 5.00 and 204.3% above the Medical Devices & Instruments industry median of 2.30. Fielmann Group AG's overall GF Score™ is 80/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year Book Growth Rate calculated?
3-Year Book Growth Rate is calculated from a company's financial statements. For Fielmann Group AG (XSWX:FIE), the current 3-Year Book Growth Rate is 7.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Fielmann Group AG (XSWX:FIE) Overvalued in 2026?
Based on GuruFocus' analysis, Fielmann Group AG stock appears to be undervalued.
The current stock price of CHF38.30 is trading 27.3% below its estimated GF Value™ of CHF52.66.
Key valuation signals for XSWX:FIE:
3-Year Book Growth Rate: 7.00% (40% above median its 10-year median of 5.00)
GF Value™: CHF52.66 vs. price of CHF38.30 (27.3% below fair value)
Industry Position: 204.3% above the Medical Devices & Instruments median (#256 of 759)
No single metric tells the full story. See the XSWX:FIE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Fielmann Group AG is involved in the purchase and sale of goods, in physical stores as well as wholesale and online, particularly in the optometric and hearing acoustics sectors, and especially sales of all kinds of vision aids - particularly glasses, eyeewear frames and lenses, sunglasses, contact lenses, accessories, hearing systems, as well as personal protective equipment. Fielmann is involved in all levels of the optical industry value-added chain: designing, manufacturing, product offering, and optician services. The group was divided into six segments: Germany, Switzerland, Austria, Spain, North America, and Other. The majority of its revenue is generated from Germany.
80GF Score
Get the complete analysis for XSWX:FIE
3-Year Book Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:FIE has been successfully added to your 
